1–2% of Your Members. Up to 15% of Your Medical Spend.
Find out what’s really behind your specialty infusion costs and how to start bringing them under control.
Specialty infusion therapy is one of the fastest-growing and least visible cost drivers in self-funded health plans. A small group of members accounts for a large share of total medical spend, but most employers never see what they’re paying for.
That’s because infusion claims typically arrive as a single bundled J-code or Q-code line. The cost of the drug and the provider’s markup are combined into one number, and that markup can reach 400%.
Our new eBook breaks down the three forces driving specialty infusion costs and gives you a practical framework to:
- Review your organization’s infusion spend with a sharper eye
- Identify where markups and site-of-care choices are inflating costs
- Evaluate solutions that can help contain rising specialty drug costs